Clinical Trial Update: Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 dose optimization study of ART621 in rheumatoid arthritis patients taking methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ART621

Snippet

Sponsor: Arana Therapeutics Ltd | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED